in postVRDVRDNLONGFIRST CALL

“$VRDN approval”

FDA approves Viridian's Lumvoa for thyroid eye disease — a major binary catalyst that sends VRDN sharply higher.

VRDVRDNLONG@ $18.31

$19.17+4.71%

since call Jun 26

peak +11.7%

Trade on Robinhood →